Kwok - Leung Cheung
University of Nottingham
Royal Derby Hospital Centre
Uttoxeter Road
DE22 3DT Derby, UNITED KINGDOM
Biography
Kwok-Leung Cheung is Professor of Breast Surgery and Medical Education, and Deputy Head of Education and Director of The BMBS Medicine Programmes at the University of Nottingham. He qualified and trained in Hong Kong, was appointed as Consultant Breast Surgeon, Nottingham University Hospitals in 2001, and is now an Honorary Consultant Breast Surgeon at the University Hospitals of Derby and Burton. Professor Cheung has clinical and research interests in breast cancer and geriatric oncology. He has served many roles in the International Society of Geriatric Oncology (SIOG) where he is currently the Present-Elect and its UK National Representative. He received SIOG’s National Representative of the Year award in 2015. Furthermore, he is a member of the Executive Committee of the European Society of Breast Cancer Specialists (EUSOMA), of the Breast Cancer Guidelines Committee of the National Institute for Health and Care Excellence (NICE) and of the Surgical Specialty Board in General Surgery at the Royal College of Surgeons of Edinburgh. Professor Cheung pioneered the Symposium on Primary Breast Cancer in Older Women in the UK, which has now become a biennial event, hosted by the University under the auspices of SIOG.
Professor Cheung has contributed specifically in one of the work packages in the Innovative collaboration for Inter-specialty cancer training across Europe (INTERACT-EUROPE) and as a Councillor of the Accreditation Council of Oncology in Europe (ACOE). Professor Cheung also leads a research project investigating the disparity of breast reconstruction in the older population across Europe.
Most relevant papers
Oncoplastic breast surgery in older women with primary breast cancer: systematic review.
Chia Z, Lee RXN, Cardoso MJ, Cheung KL, Parks RM.Br J Surg. 2023 Sep 6;110(10):1309-1315. doi: 10.1093/bjs/znad161.PMID: 37310128
Revisiting primary endocrine therapy versus surgery in older women with breast cancer: meta-analysis.
Chan KS, Chong MTH, Chia CLK, Cheung KL.Br J Surg. 2023 Mar 30;110(4):420-431. doi: 10.1093/bjs/znac435.PMID: 36718056
Immediate breast reconstruction uptake in older women with primary breast cancer: systematic review.
Lee RXN, Cardoso MJ, Cheung KL, Parks RM.Br J Surg. 2022 Oct 14;109(11):1063-1072. doi: 10.1093/bjs/znac251.PMID: 35909248
Improving outcomes for women aged 70 years or above with early breast cancer: research programme including a cluster RCT.
Wyld L, Reed MWR, Collins K, Ward S, Holmes G, Morgan J, Bradburn M, Walters S, Burton M, Lifford K, Edwards A, Brain K, Ring A, Herbert E, Robinson TG, Martin C, Chater T, Pemberton K, Shrestha A, Nettleship A, Richards P, Brennan A, Cheung KL, Todd A, Harder H, Audisio R, Battisti NML, Wright J, Simcock R, Murray C, Thompson AM, Gosney M, Hatton M, Armitage F, Patnick J, Green T, Revill D, Gath J, Horgan K, Holcombe C, Winter M, Naik J, Parmeshwar R.Southampton (UK): National Institute for Health and Care Research; 2022 Jun.PMID: 35793425
Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG).
Biganzoli L, Battisti NML, Wildiers H, McCartney A, Colloca G, Kunkler IH, Cardoso MJ, Cheung KL, de Glas NA, Trimboli RM, Korc-Grodzicki B, Soto-Perez-de-Celis E, Ponti A, Tsang J, Marotti L, Benn K, Aapro MS, Brain EGC.Lancet Oncol. 2021 Jul;22(7):e327-e340. doi: 10.1016/S1470-2045(20)30741-5. Epub 2021 May 14.PMID: 34000244
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial.
Robertson JFR, Bondarenko IM, Trishkina E, Dvorkin M, Panasci L, Manikhas A, Shparyk Y, Cardona-Huerta S, Cheung KL, Philco-Salas MJ, Ruiz-Borrego M, Shao Z, Noguchi S, Rowbottom J, Stuart M, Grinsted LM, Fazal M, Ellis MJ.Lancet. 2016 Dec 17;388(10063):2997-3005. doi: 10.1016/S0140-6736(16)32389-3. Epub 2016 Nov 29.PMID: 27908454
Human epidermal growth receptor-2 overexpressing early operable primary breast cancers in older (≥70 years) women: biology and clinical outcome in comparison with younger (<70 years) patients.
Syed BM, Green AR, Ellis IO, Cheung KL.Ann Oncol. 2014 Apr;25(4):837-842. doi: 10.1093/annonc/mdu028.PMID: 24667716
Biology of primary breast cancer in older women treated by surgery: with correlation with long-term clinical outcome and comparison with their younger counterparts.
Syed BM, Green AR, Paish EC, Soria D, Garibaldi J, Morgan L, Morgan DA, Ellis IO, Cheung KL.Br J Cancer. 2013 Mar 19;108(5):1042-51. doi: 10.1038/bjc.2012.601. Epub 2013 Mar 5.PMID: 23462719
A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up.
Johnston SJ, Kenny FS, Syed BM, Robertson JFR, Pinder SE, Winterbottom L, Ellis IO, Blamey RW, Cheung KL.Ann Oncol. 2012 Sep;23(9):2296-2300. doi: 10.1093/annonc/mdr630. Epub 2012 Feb 21.PMID: 22357257
Long-term (37 years) clinical outcome of older women with early operable primary breast cancer managed in a dedicated clinic.
Syed BM, Johnston SJ, Wong DW, Green AR, Winterbottom L, Kennedy H, Simpson N, Morgan DA, Ellis IO, Cheung KL.Ann Oncol. 2012 Jun;23(6):1465-71. doi: 10.1093/annonc/mdr446. Epub 2011 Oct 14.PMID: 22003241
